Europe streamlined approval process to weeks to fight COVID-19 pandemic. Why does it take more than a decade to get a GMO safety review?

european parliament

At the start of the pandemic, China built a hospital in double-quick time and we all thought, “that’s why they are so good at economic growth”. Then Britain did the same, proving we can do it too. Medical devices have been rushed through the approval process in days. Vaccine development is being brilliantly accelerated. We have shown we can do things quickly. Why can’t we do the same in ordinary times?

In 2005, the European Food Safety Authority (EFSA) approved a genetically modified variety of potato bred by the German company BASF.

The European Commission decided not to decide. So BASF went to court and won. The commission launched another evaluation. The EFSA once again said the potato was safe. But the Hungarian government complained the EU had based its decision on the first approval, instead of the second virtually identical one. A court agreed.


By this time, eight years had passed and BASF had tired of banging its head against a brick wall. It withdrew its application, packed up its research team and moved them to America.

Related article:  Viewpoint: GMO crops are key to sustainable farming—why are some scientists afraid to talk about them?

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend